SE8100011L - CANCER CELL DETECTION - Google Patents
CANCER CELL DETECTIONInfo
- Publication number
- SE8100011L SE8100011L SE8100011A SE8100011A SE8100011L SE 8100011 L SE8100011 L SE 8100011L SE 8100011 A SE8100011 A SE 8100011A SE 8100011 A SE8100011 A SE 8100011A SE 8100011 L SE8100011 L SE 8100011L
- Authority
- SE
- Sweden
- Prior art keywords
- specific
- antibodies
- antisera
- nucleolar antigen
- human
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- G01N33/57595—
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Detergent Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Specific nucleolar antigen(s) are found common to a broad range of human malignant tumor specimens and have been isolated, extracted and purified. Antibodies and antisera specific to these nucleolar antigen(s) are harvested from non-human hosts and used for detection of human cancer cells. Disclosed are (1) methods for isolating the nucleolar antigen(s), obtaining them in substantially purified form, producing the specific antibodies, obtaining them in substantially purified form, and using the antisera and antibodies induced by the nucleolar antigen(s) in diagnostic procedures for detecting human cancer cells, and (2) diagnostic kits comprising specific antibodies and antisera.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000343088A CA1157373A (en) | 1980-01-04 | 1980-01-04 | Detection of human cancer cells with antibodies to human cancer nucleolar antigen(s) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8100011L true SE8100011L (en) | 1981-07-05 |
| SE450665B SE450665B (en) | 1987-07-13 |
Family
ID=4115973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8100011A SE450665B (en) | 1980-01-04 | 1981-01-02 | NUCLEOLATED ANTIGENS FROM CANCER CELLS, PREPARATION OF SIMILAR ANTIBODIES AND REAGENT SOLUTION CONTAINING LABELED ANTIBODIES |
Country Status (27)
| Country | Link |
|---|---|
| JP (1) | JPS56101553A (en) |
| KR (1) | KR850001770B1 (en) |
| AR (1) | AR232046A1 (en) |
| AT (1) | AT373397B (en) |
| AU (1) | AU535024B2 (en) |
| BE (1) | BE886935A (en) |
| CA (1) | CA1157373A (en) |
| CH (1) | CH659328A5 (en) |
| DE (1) | DE3047654A1 (en) |
| DK (1) | DK554980A (en) |
| ES (2) | ES498305A0 (en) |
| FI (1) | FI810007A7 (en) |
| FR (1) | FR2484650B1 (en) |
| GB (1) | GB2067286B (en) |
| GR (1) | GR72850B (en) |
| IE (1) | IE50760B1 (en) |
| IL (1) | IL61641A (en) |
| IT (1) | IT1172216B (en) |
| LU (1) | LU83015A1 (en) |
| NL (1) | NL8007128A (en) |
| NO (2) | NO803910L (en) |
| NZ (1) | NZ195756A (en) |
| OA (1) | OA06713A (en) |
| PH (5) | PH18765A (en) |
| PT (1) | PT72301B (en) |
| SE (1) | SE450665B (en) |
| ZA (1) | ZA807754B (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4487830A (en) * | 1982-05-14 | 1984-12-11 | American Hoechst Corporation | Enzyme/immunofluorescent assay for autoantibodies |
| JPS5990052A (en) * | 1982-11-16 | 1984-05-24 | Katsu Taniguchi | Melanoma diagnosis medicine using monoclonal specific antibody |
| US4871661A (en) * | 1983-11-23 | 1989-10-03 | The Ohio State University Research Foundation | Process for testing the carcinogenicity of a material or the presence of cancer-inducing factors in an environment |
| US4746539A (en) * | 1983-11-23 | 1988-05-24 | The Ohio State University Research Foundation | Purification of cancer-associated protein and preparation of antibody thereto |
| EP0145373B1 (en) * | 1983-11-23 | 1992-03-25 | The Ohio State University Research Foundation | Purification of cancer-associated protein and preparation of antibody thereto |
| US4645737A (en) * | 1984-03-05 | 1987-02-24 | American Hoechst Corporation | Enzyme/immunofluorescent assay for anti-treponemal antibodies |
| US4607008A (en) * | 1984-03-05 | 1986-08-19 | American Hoechst Corporation | Enzyme/immunofluorescent assay for anti-Epstein-Barr Virus antibodies |
| ATE76509T1 (en) * | 1984-05-02 | 1992-06-15 | Univ Research Corp | IMMUNOLOGICAL TEST PROCEDURE OF A PROCOAGULATING ENZYME FOR THE DETECTION OF CANCER. |
| US4616658A (en) * | 1985-02-27 | 1986-10-14 | William Shell | Non-radioactively labeled microspheres and use of same to measure blood flow |
| US4798719A (en) * | 1986-09-11 | 1989-01-17 | University Of Pittsburgh | Method for selection of antigens suitable as in vivo targets for antibodies |
| US4861581A (en) * | 1986-12-05 | 1989-08-29 | Cancer Biologics, Inc. | Detection of necrotic malignant tissue and associated therapy |
| US5019368A (en) * | 1989-02-23 | 1991-05-28 | Cancer Biologics, Inc. | Detection of necrotic malignant tissue and associated therapy |
| CA2023030A1 (en) * | 1990-07-13 | 1992-01-14 | Robert R. Guerrero | In vitro method and probe for detecting the presence of the ring shaped particle and malignancy in humans and animals |
-
1980
- 1980-01-04 CA CA000343088A patent/CA1157373A/en not_active Expired
- 1980-12-04 AU AU65070/80A patent/AU535024B2/en not_active Ceased
- 1980-12-04 IE IE2533/80A patent/IE50760B1/en unknown
- 1980-12-04 NZ NZ195756A patent/NZ195756A/en unknown
- 1980-12-05 IL IL61641A patent/IL61641A/en unknown
- 1980-12-10 ZA ZA00807754A patent/ZA807754B/en unknown
- 1980-12-15 PH PH24978A patent/PH18765A/en unknown
- 1980-12-17 DE DE19803047654 patent/DE3047654A1/en active Granted
- 1980-12-18 LU LU83015A patent/LU83015A1/en unknown
- 1980-12-22 NO NO803910A patent/NO803910L/en unknown
- 1980-12-22 AR AR283753A patent/AR232046A1/en active
- 1980-12-27 JP JP18948880A patent/JPS56101553A/en active Pending
- 1980-12-29 DK DK554980A patent/DK554980A/en not_active Application Discontinuation
- 1980-12-30 CH CH9652/80A patent/CH659328A5/en not_active IP Right Cessation
- 1980-12-30 KR KR1019800005026A patent/KR850001770B1/en not_active Expired
- 1980-12-31 PT PT72301A patent/PT72301B/en unknown
- 1980-12-31 GB GB8041638A patent/GB2067286B/en not_active Expired
- 1980-12-31 BE BE0/203378A patent/BE886935A/en not_active IP Right Cessation
- 1980-12-31 NL NL8007128A patent/NL8007128A/en not_active Application Discontinuation
-
1981
- 1981-01-02 FI FI810007A patent/FI810007A7/en not_active Application Discontinuation
- 1981-01-02 ES ES498305A patent/ES498305A0/en active Granted
- 1981-01-02 SE SE8100011A patent/SE450665B/en not_active IP Right Cessation
- 1981-01-02 FR FR8100014A patent/FR2484650B1/en not_active Expired
- 1981-01-05 IT IT67001/81A patent/IT1172216B/en active
- 1981-01-05 OA OA57289A patent/OA06713A/en unknown
- 1981-01-05 AT AT0001081A patent/AT373397B/en not_active IP Right Cessation
- 1981-01-05 GR GR63789A patent/GR72850B/el unknown
-
1982
- 1982-02-01 ES ES509239A patent/ES8307377A1/en not_active Expired
-
1983
- 1983-02-21 PH PH28550A patent/PH18129A/en unknown
- 1983-02-21 PH PH28549A patent/PH18636A/en unknown
- 1983-02-21 PH PH28547A patent/PH18637A/en unknown
- 1983-02-21 PH PH28548A patent/PH18624A/en unknown
-
1985
- 1985-01-02 NO NO850005A patent/NO850005L/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE8100011L (en) | CANCER CELL DETECTION | |
| DK393886A (en) | MONOCLONE ANTIBODIES AND ANTIGEN FOR HUMAN NON-SMALL CELLAR LUNGCARCINOMES | |
| ES8507694A1 (en) | A method for the preparation of monoclonal antibody with specificity for crosslinked fibrin derivatives and an assay procedure using said antibody. | |
| FI803756L (en) | HYBRIDCELLINJE FOER FRAMSTAELLNING AV MONOCLONISK ANTIKROPP TILL TIDIG TYMOCYT ANTIGEN AV MAENNISKAN ANTIKROPP OCH METODER | |
| DE3789781D1 (en) | Antigens, antibodies and methods for identifying human metastatic tumors and cell lines for the production of these antibodies. | |
| DK314586A (en) | MONOCLONAL ANTIBODIES AND ANTIGENS FOR HUMAN LUNGCARCINOMES NON-SMALL CELL TYPE | |
| ATE9846T1 (en) | RADIOIMMUNOASSAY FOR MIGRATION INHIBITION FACTOR. | |
| SE8205891D0 (en) | ALFA-L ANTIBODY AND SET FOR PRODUCING THEREOF | |
| EP0226468A3 (en) | Detection of human cancer cells with antibodies to human cancer nucleolar antigen p145 | |
| DK247486A (en) | MONOCLONE ANTIBODIES AND THEIR USE | |
| IT1148013B (en) | PROCEDURE FOR OBTAINING TOXOPLASM PREPARATIONS FOR THE DIAGNOSIS OF TOXOPLASMOSIS AND PREPARATIONS SO OBTAINED | |
| Wright Jr et al. | Isolation of a soluble tumor-associated antigen from human renal cell carcinoma by gradient acrylamide gel electrophoresis | |
| JPS51146897A (en) | Method of determination of existence of malignant sickness by analyzing biological cell specimen | |
| EP0248147A3 (en) | Method of determining the presence of cancer cells | |
| Levin et al. | Ability of animals to give a humoral immune response and its effect on development of experimental leukemias | |
| JPS5270017A (en) | Novel method for immono-assay | |
| DE3586628D1 (en) | Immunoassay for detecting cells producing intestinal mucin antigen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 8100011-9 Effective date: 19910805 Format of ref document f/p: F |